Imigran Fdt

Sumatriptan, the active ingredient in Imigran Fdt, is a selective serotonin (5‑HT1B/1D) receptor agonist presented as a tablet for oral use. It provides rapid relief of migraine headache pain and associated symptoms such as nausea, photophobia, and phonophobia in adult patients experiencing an acute migraine attack.

GNH USA supplies Imigran Fdt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures consistent quality and regulatory compliance across global markets.

Imigran Fdt (sumatriptan) is indicated for acute migraine treatment, acting on the trigeminovascular system.

Migraine attacks: provides rapid relief of headache pain and associated symptoms. Migraine with aura: alleviates headache and neurological aura symptoms. Migraine without aura: aborts headache pain quickly. Cluster headache episodes: reduces severity of attacks when used early. Acute episodic migraine: aborts headache when taken at onset.

Imigran Fdt may cause a range of adverse reactions.

Common Side Effects: - Chest discomfort: mild pressure or tightness in the chest. - Tingling or numbness: sensation in fingers, toes, or face. - Flushing: transient redness of the skin. - Dizziness: light‑headed feeling.

Serious or Rare Side Effects: - Serotonin syndrome: potentially life‑threatening condition when combined with other serotonergic agents. - Cardiac ischemia: chest pain due to reduced coronary blood flow. - Severe allergic reaction: rash, swelling, or anaphylaxis.

When prescribing Imigran Fdt, clinicians should consider several precautionary measures to ensure patient safety.

Cardiovascular disease: avoid use in patients with uncontrolled coronary artery disease or recent myocardial infarction. History of stroke: contraindicated in patients with prior cerebrovascular events. Concomitant serotonergic drugs: assess risk of serotonin syndrome when combined with SSRIs, SNRIs, or MAO inhibitors. Pregnancy and lactation: use only if potential benefit outweighs risk, as safety data are limited. Store at ambient temperature: keep below 25 °C in the original packaging, protect from moisture.

Imigran Fdt can interact with several medication classes, requiring careful review.

Major Interactions (Avoid): - MAO inhibitors: risk of severe hypertension and serotonin syndrome; avoid concurrent use. - Ergot alkaloids: combined vasoconstriction may cause coronary spasm; avoid.

Moderate Interactions (Monitor Closely): - SSRIs and SNRIs: monitor for signs of serotonin syndrome. - Use of multiple triptans: avoid using more than one triptan within 24 hours. - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase sumatriptan plasma levels; adjust dose if necessary.